Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Qing-Ping Shao, Chen Wei, Jie Yang & Wen-Zhou Zhang. (2020) miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway. OncoTargets and Therapy 13, pages 7213-7227.
Read now
Read now
Ying-Qi Feng, Bo-An Li, Fan Feng, Yong-Shou Chen, Yi-Xin Ren, Heng Zhang & Shuang Cao. (2020) Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents. OncoTargets and Therapy 13, pages 7165-7176.
Read now
Read now
Leisheng Wang, He En, Lei Yang, Yanbing Zhang, Baisheng Sun & Jianjiang Gao. (2019) miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib. OncoTargets and Therapy 12, pages 6825-6838.
Read now
Read now
Yan Huo, Qun Wang, Ying Liu, Junyi Wang, Qian Li, Zongyuan Li, Yan Dong, Yifei Huang & Liqiang Wang. (2019) A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells. OncoTargets and Therapy 12, pages 6069-6082.
Read now
Read now
Hong-qing Zhou, Ming-sheng Liu, Ti-bin Deng, Ping-bo Xie, Wei Wang, Tao Shao, Yao Wu & Peng Zhang. (2019) The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells. OncoTargets and Therapy 12, pages 7809-7821.
Read now
Read now
Du Meng, Hongwei Lei, Xiaoqiang Zheng, Yaxuan Han, Ronggang Sun, Dongli Zhao & Rui Liu. (2019) A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells. OncoTargets and Therapy 12, pages 3919-3931.
Read now
Read now
Articles from other publishers (18)
Ajaykumar C. Morani, Nisha S. Ramani, Sireesha Yedururi & Srinivasa R. Prasad. (2022) Malignant Gastrointestinal Neuroectodermal Tumor: A New Kid on the Block?. Journal of Computer Assisted Tomography 46:5, pages 676-681.
Crossref
Crossref
Chaochao Zhao, Qin Shi, Hu Li, Xi Cui, Yuan Xi, Yu Cao, Zhuo Xiang, Feng Li, Jinyan Sun, Jiacheng Liu, Tongqiang Li, Wei Wei, Bin Xiong & Zhou Li. (2022)
Shape Designed Implanted Drug Delivery System for
In Situ
Hepatocellular Carcinoma Therapy
. ACS Nano 16:5, pages 8493-8503.
Crossref
Crossref
Baisheng Sun, Yin Long, Ling Xiao, Jiazhi Wang, Qian Yi, Dali Tong & Ke Li. (2022) Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells. Journal of Oncology 2022, pages 1-10.
Crossref
Crossref
Mohammad R. Nikmaneshi, Bahar Firoozabadi & Aliasghar Mozafari. (2021) Chemo‐mechanistic multi‐scale model of a three‐dimensional tumor microenvironment to quantify the chemotherapy response of cancer. Biotechnology and Bioengineering 118:10, pages 3871-3887.
Crossref
Crossref
Xiao-zheng Zou, Xiu-hua Zhou, Ying-qi Feng, Jun-feng Hao, Bing Liang & Meng-wei Jia. (2021) Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. European Journal of Pharmacology 907, pages 174222.
Crossref
Crossref
Yamin Jie, Guijun Liu, Mingyan E, Ying Li, Guo Xu, Jingjing Guo, Yinyin Li, Guanghua Rong, Yongwu Li & Anxin Gu. (2021) Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma. European Journal of Pharmacology 906, pages 174214.
Crossref
Crossref
Junxiao Wang, Rui Liu, Yun Zhao, Zhenhu Ma, Zejie Sang, Zhenyu Wen, Xueling Yang & Hui Xie. (2021) Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Frontiers in Oncology 11.
Crossref
Crossref
Qiong Wu, Tian-yi Liu, Bai-chun Hu, Xiang Li, Yu-ting Wu, Xiao-tong Sun, Xiao-wen Jiang, Shu Wang, Xiao-chun Qin, Huai-wei Ding & Qing-chun Zhao. (2021) CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways. Frontiers in Oncology 11.
Crossref
Crossref
Boan Li, Fan Feng, Hui Jia, Qiyu Jiang, Shuang Cao, Ling Wei, Yingshi Zhang & Jincai Lu. (2021)
Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells
via
the miR-148a/PXR axis
. Food & Function 12:6, pages 2404-2417.
Crossref
Crossref
Wei Zhou, Yongping Gao, Yaqi Tong, Qingjun Wu, Yunzhi Zhou & Yanming Li. (2021) Anlotinib enhances the antitumor activity of radiofrequency ablation on lung squamous cell carcinoma. Pharmacological Research 164, pages 105392.
Crossref
Crossref
Tao Sun, Yanqiao Ren, Xuefeng Kan, Lei Chen, Weihua Zhang, Fan Yang & Chuansheng Zheng. (2020) Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Chunzhan Wang, Shengguang Ding, Baisheng Sun, Liang Shen, Ling xiao, Zhihai Han & Haitao Huang. (2020) Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib. Pharmacological Research 161, pages 105110.
Crossref
Crossref
Hua Yang, Lili Ren, Yanan Wang, Xuebing Bi, Xiaoli Li, Ming Wen, Qian Zhang, Yang Yang, Youchao Jia, Yumiao Li, Aimin Zang, Yaning wei & Guanghai Dai. (2020) FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis. Cell Death & Disease 11:10.
Crossref
Crossref
Yan Ma, Ningli Chai, Qiyu Jiang, Zhengyao Chang, Yantao Chai, Xiaojuan Li, Huiwei Sun, Jun Hou & Enqiang Linghu. (2020) DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. Pharmacological Research 160, pages 105071.
Crossref
Crossref
De-bin Ma, Meng-meng Qin, Liang Shi & Xin-min Ding. (2019) MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway. Cellular Signalling 64, pages 109391.
Crossref
Crossref
Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li & Jun Hou. (2019) Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model. Animal Models and Experimental Medicine 2:4, pages 259-268.
Crossref
Crossref
Bin Yang, Chunping Wang, Hui Xie, Yiwu Wang, Jiagan Huang, Yihui Rong, Huixin Zhang, Huifang Kong, Yongping Yang & Yinying Lu. (2019) MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death & Disease 10:10.
Crossref
Crossref
Fan Feng, Xiaojuan Li, Ruisheng Li & Boan Li. (2019) The multiple‐kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells. Animal Models and Experimental Medicine 2:3, pages 178-184.
Crossref
Crossref